Zhejiang Jiuzhou Pharmaceutical Hits Day Low Amid Price Pressure at CNY 16.45

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.0% on March 3, 2026. The stock reached an intraday low of CNY 16.45, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 6.57%, contrasting with a slight gain of 0.41% in the China Shanghai Composite index. In terms of longer-term performance, Zhejiang Jiuzhou has faced significant challenges, with a 57.39% decline over the past three years and a 54.92% drop over the last five years. Despite these setbacks, the company has managed to generate an 18.12% return over the past year, although profits have decreased by 25.7% during the same period. The company's market capitalization stands at CNY 15,762 million, and it maintains a price-to-earnings ratio of 26.00. With a return on equity of 8.26% and a price-to-book ratio of 1.80, Zhejiang Jiuzhou continues to navigate a complex market landscape within the pharmaceuticals and biotechnology sector.